![Role of glucagon-like peptides in inflammatory bowel diseases—current knowledge and future perspectives | SpringerLink Role of glucagon-like peptides in inflammatory bowel diseases—current knowledge and future perspectives | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00210-019-01698-z/MediaObjects/210_2019_1698_Fig2_HTML.png)
Role of glucagon-like peptides in inflammatory bowel diseases—current knowledge and future perspectives | SpringerLink
![Glucagon-like Peptide 2 (GLP-2) Peptide Molecule. Its Recombinant Analog Teduglutide is Used To Treat Short-Bowel Syndrome, an Stock Illustration - Illustration of polymer, magnetic: 187042201 Glucagon-like Peptide 2 (GLP-2) Peptide Molecule. Its Recombinant Analog Teduglutide is Used To Treat Short-Bowel Syndrome, an Stock Illustration - Illustration of polymer, magnetic: 187042201](https://thumbs.dreamstime.com/z/glucagon-like-peptide-glp-molecule-its-recombinant-analog-teduglutide-used-to-treat-short-bowel-syndrome-orphan-disease-wire-187042201.jpg)
Glucagon-like Peptide 2 (GLP-2) Peptide Molecule. Its Recombinant Analog Teduglutide is Used To Treat Short-Bowel Syndrome, an Stock Illustration - Illustration of polymer, magnetic: 187042201
![PDF] Synergy of glucagon-like peptide-2 and epidermal growth factor coadministration on intestinal adaptation in neonatal piglets with short bowel syndrome. | Semantic Scholar PDF] Synergy of glucagon-like peptide-2 and epidermal growth factor coadministration on intestinal adaptation in neonatal piglets with short bowel syndrome. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/46a296e081b14acd2e895a59805fd3f2aebf185e/3-Figure1-1.png)
PDF] Synergy of glucagon-like peptide-2 and epidermal growth factor coadministration on intestinal adaptation in neonatal piglets with short bowel syndrome. | Semantic Scholar
![Glucagon-like Peptide 2 (GLP-2) Peptide Molecule. Its Recombinant Analog Teduglutide Is Used To Treat Short-Bowel Syndrome, An Orphan Disease. Cartoon & Wire Representation. Secondary Structure Coloring. Stock Photo, Picture And Royalty Free Glucagon-like Peptide 2 (GLP-2) Peptide Molecule. Its Recombinant Analog Teduglutide Is Used To Treat Short-Bowel Syndrome, An Orphan Disease. Cartoon & Wire Representation. Secondary Structure Coloring. Stock Photo, Picture And Royalty Free](https://previews.123rf.com/images/molekuul/molekuul1311/molekuul131100127/24079276-glucagon-like-peptide-2-glp-2-peptide-molecule-its-recombinant-analog-teduglutide-is-used-to-treat-s.jpg)
Glucagon-like Peptide 2 (GLP-2) Peptide Molecule. Its Recombinant Analog Teduglutide Is Used To Treat Short-Bowel Syndrome, An Orphan Disease. Cartoon & Wire Representation. Secondary Structure Coloring. Stock Photo, Picture And Royalty Free
![PDF] The Discovery of GLP-2 and Development of Teduglutide for Short Bowel Syndrome. | Semantic Scholar PDF] The Discovery of GLP-2 and Development of Teduglutide for Short Bowel Syndrome. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/71d9ebf659f59b27bb8cce79691e862ba753aede/5-Figure3-1.png)
PDF] The Discovery of GLP-2 and Development of Teduglutide for Short Bowel Syndrome. | Semantic Scholar
![Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial - The Lancet Gastroenterology & Hepatology Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial - The Lancet Gastroenterology & Hepatology](https://www.thelancet.com/cms/attachment/418fc973-9e86-48ff-98dc-4d4d2addb9b0/gr2.gif)
Glepaglutide, a novel long-acting glucagon-like peptide-2 analogue, for patients with short bowel syndrome: a randomised phase 2 trial - The Lancet Gastroenterology & Hepatology
The Discovery of GLP-2 and Development of Teduglutide for Short Bowel Syndrome | ACS Pharmacology & Translational Science
![The Discovery of GLP-2 and Development of Teduglutide for Short Bowel Syndrome | ACS Pharmacology & Translational Science The Discovery of GLP-2 and Development of Teduglutide for Short Bowel Syndrome | ACS Pharmacology & Translational Science](https://pubs.acs.org/cms/10.1021/acsptsci.9b00016/asset/images/large/pt-2019-00016v_0004.jpeg)
The Discovery of GLP-2 and Development of Teduglutide for Short Bowel Syndrome | ACS Pharmacology & Translational Science
![Segmental reversal of the distal small intestine in a short bowel syndrome model in piglets showed detrimental effect on weight gain | BMC Gastroenterology | Full Text Segmental reversal of the distal small intestine in a short bowel syndrome model in piglets showed detrimental effect on weight gain | BMC Gastroenterology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12876-022-02418-3/MediaObjects/12876_2022_2418_Fig2_HTML.png)
Segmental reversal of the distal small intestine in a short bowel syndrome model in piglets showed detrimental effect on weight gain | BMC Gastroenterology | Full Text
![Glucagon-like peptide 2 (GLP-2) peptide molecule. Its recombinant analog teduglutide is used to treat Short-Bowel Syndrome Stock Photo - Alamy Glucagon-like peptide 2 (GLP-2) peptide molecule. Its recombinant analog teduglutide is used to treat Short-Bowel Syndrome Stock Photo - Alamy](https://c8.alamy.com/zooms/6/867d98df5f9b40cc8f08db253206ba90/djfm9h.jpg)
Glucagon-like peptide 2 (GLP-2) peptide molecule. Its recombinant analog teduglutide is used to treat Short-Bowel Syndrome Stock Photo - Alamy
![GLP2: an underestimated signal for improving glycaemic control and insulin sensitivity in: Journal of Endocrinology Volume 229 Issue 2 (2016) GLP2: an underestimated signal for improving glycaemic control and insulin sensitivity in: Journal of Endocrinology Volume 229 Issue 2 (2016)](https://joe.bioscientifica.com/view/journals/joe/229/2/images/large/R57fig1.jpeg)
GLP2: an underestimated signal for improving glycaemic control and insulin sensitivity in: Journal of Endocrinology Volume 229 Issue 2 (2016)
![The Discovery of GLP-2 and Development of Teduglutide for Short Bowel Syndrome | ACS Pharmacology & Translational Science The Discovery of GLP-2 and Development of Teduglutide for Short Bowel Syndrome | ACS Pharmacology & Translational Science](https://pubs.acs.org/cms/10.1021/acsptsci.9b00016/asset/images/large/pt-2019-00016v_0001.jpeg)
The Discovery of GLP-2 and Development of Teduglutide for Short Bowel Syndrome | ACS Pharmacology & Translational Science
![Review article: a comparison of glucagon‐like peptides 1 and 2 - Janssen - 2013 - Alimentary Pharmacology & Therapeutics - Wiley Online Library Review article: a comparison of glucagon‐like peptides 1 and 2 - Janssen - 2013 - Alimentary Pharmacology & Therapeutics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/46b72ea0-ceca-437d-a306-a7a01b1ef17a/apt12092-fig-0006-m.jpg)